ANTI-GD2-ANTIKÖRPER

European patent · EP3323830 · In force

Register entry

Publication number
EP3323830
Application number
EP17191451
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jun 20, 2011
Published
May 23, 2018
Granted
Aug 23, 2023
Protection ends at the latest
Jun 19, 2031
Next annual fee due
Jun 30, 2027
IPC classes
C07K 16/00 (2006.01)
A61K 39/395 (2006.01)
C12N 5/07 (2010.01)
Priority
US 397920 P 19.06.2010
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 4, 2026

    Agent entered

    Representative
    Pintz & Partners LLC, c/o Frey Services, Eggstrasse 14f, 8134 Adliswil

    Published in Swissreg on 04.09.2026

  2. Jul 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.06.2026 → 30.06.2027

    Published in Swissreg on 01.07.2026

  3. Jul 1, 2025

    Next annual fee due on

    Next annual fee due on
    30.06.2025 → 30.06.2026

    Published in Swissreg on 01.07.2025

  4. Jul 4, 2024

    Change

    Published in Swissreg on 04.07.2024

  5. Jul 3, 2024

    Change

    Published in Swissreg on 03.07.2024

  6. Aug 23, 2023

    Granted

    Published in Swissreg on 23.08.2023

Parties

Holder

Memorial Sloan-Kettering Cancer Center

1275 York Avenue, New York, NY 10065, US

Agent

Pintz & Partners LLC

c/o Frey Services Eggstrasse 14f, 8134 Adliswil

Inventor

Ahmed, Mahiuddin

Corona, NY 11368, US

Cheung, Nai-Kong

Purchase, NY 10577, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.